Full Hold at current weight with mechanical triggers; structural quality forecloses sell while cyclical timing forecloses overweight
The HOLD verdict reconciles three binding facts: (1) Structural case forecloses Sell — LRCX posted Q3 FY26 revenue +30% YoY at record $6.72B, operating margins 37.4%, ROE 65%, gross margins at 4-year high of 50.5%, $5.58B cash against $3.73B debt ($1.84B net cash), $5B+ annual buybacks, deferred revenue rising ($2.28B), and management describing order book as sold out through 2026. Forward EPS of $11.65 provides mechanical multiple compression at ~23x forward P/E. (2) Cyclical timing and macro stack foreclose Buy/Overweight — forward EPS of $11.65 implies +72-81% revenue growth, roughly double LRCX's all-time peak (+33%); AR +58% YoY versus revenue +26% YoY (2.2x ratio); FCF fell from $5.41B (FY25) to $4.89B (FY26) despite higher net income; Q4 FCF dropped 47% sequentially. Memory cycle exposure is structural risk: HBM capex buildout projects to complete by mid-2027 (FY27 H2). Macro stack is hostile: 10Y yield near 5%, Fed hiked Sep 16, ~95% probability of zero cuts in 2026, recession odds rose 50% in one week, Beta 1.86. Technical setup not confirming bottom: MACD histogram -3.59, 50 SMA falling $338 → $310 in one month, RSI 36. (3) Prior lesson stack forecloses both aggressive alternatives — three consecutive prior Holds produced negative alpha (-1.0%, -5.0%, -0.8%), and 9/11 Hold lost -7.8% alpha even with 90% sizing and collar hedge. Mid-sized adjustments deliver alpha noise rather than alpha signal. Mechanical triggers govern all position adjustments.
| Position | Action |
|---|---|
| Daily close > $289.41 with volume >8M AND macro cooperation (10Y < 4.75% or dovish Fed guidance) | Upgrade to Overweight |
| Daily close < $265.77 on volume >10M | Trim 50% |
| Daily close < $250 on volume with macro stack hostile (10Y > 5%, recession odds > 20%) | Exit cleanly |
| DSO extends to 80+ days OR AR growth continues to outpace revenue growth by 30+ percentage points in Q1 FY27 | Downgrade to Underweight |
LRCX's 38% pullback from June highs is a tactical correction within a secular uptrend, not a structural breakdown, supported by a sold-out order book, 200 SMA support, expanding margins, and 23.1x forward P/E that already discounts the bear case.
| Indicator | Value | Signal |
|---|---|---|
| Price Close | 269.23 | neutral |
| Price Open | 277.00 | neutral |
| Price Low | 265.78 | neutral |
| Price High | 277.78 | neutral |
| 10 EMA | 289.41 | bearish |
| 50 SMA | 309.96 | bearish |
| 200 SMA | 265.77 | neutral |
| RSI (14) | 36.03 | bearish |
| MACD | -9.61 | bearish |
| MACD Signal Line | -6.02 | bearish |
| MACD Histogram | -3.59 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
EV: Target 1: +15% to 50 SMA at $310; Target 2: $400+ on full trend reassertion (+48% from $269.23); Stop: daily close below $250 · concedes: Next 1-4 weeks could be choppy; If LRCX closes below $265.77 on volume >10M, that would be a real breakdown signal and the 200 SMA gives way; Fed hike makes macro regime less friendly near-term; AMAT comparison is a real relative-value consideration (more end-market diversification); Bear needs only one of three things (margin expansion, WFE spending, AI capex) to go wrong to flatten returns, while bull needs only one of three to go right for 30-50% gains
LRCX is a high-quality company in a cyclical position near its peak, not the beginning of a new cycle—the "sold-out" backlog is a peak signal, receivables are warning of demand softening, the Fed hike is fresh and unpriced, and technicals haven't confirmed a bottom, making the risk/reward unfavorable at current levels.
· concedes: ROE of 65%, gross margins at four-year high, and FY26 revenue +26% are all real and not fake; AMAT might be more diversified than LRCX; Zacks calling AMAT 'safer' is a real signal that institutional buyers are rotating; LRCX is a high-quality company with strong fundamentals on a TTM basis
→ vs conservative: Receivables argument misreads demand pull-forward as late-cycle collection risk when management explicitly stated customers want tools sooner than supply allows
→ vs conservative: Sold-out peak signal argument is survivorship bias from memory cycles; clean room capacity bottleneck with visible accelerating AI demand is structurally different from prior cycles
→ vs conservative: TTM P/E of 47x is meaningless; forward P/E of 23x with EPS doubling trajectory is the relevant metric and represents a gift, not a risk
→ vs conservative: 200 SMA hold is 1.3 percent but that is where generational wealth gets created; ATR compression historically resolves explosively higher when fundamentals support it
→ vs conservative: Fed hike on September 16 is already in price; waiting for macro stabilization means missing the move to 320
→ vs neutral: Alternative AMAT pick represents diversification value-trap; focused killer in etch/deposition beats diversified conglomerate in AI upcycle
| Bollinger Middle Band (20 SMA) | 300.81 | bearish |
| Bollinger Upper Band | 332.26 | bearish |
| Bollinger Lower Band | 269.36 | bearish |
| ATR (14) | 15.66 | neutral |
| Volume | 6.93M | neutral |
| 30-Day Avg Volume | ~10M | neutral |
Support: 269.36 · 265.78 · 250 | Resistance: 289.41 · 300.81 · 309.96
LRCX is in a post-blowoff correction phase after parabolic run from ~$95 (Aug 2025) to all-time high of 438.50 (2026-06-30), followed by ~38% drawdown to 269.23. Short-term and medium-term trends are bearish across all moving averages, but the 200 SMA at 265.77 represents the critical long-term support/pivot level — a level of major historical significance. No death cross has occurred yet (50 SMA at 309.96 still above 200 SMA at 265.77), but the gap is closing fast. ATR at 15.66 is declining from August peak of 28+, suggesting volatility is normalizing and a volatility squeeze may be setting up. Tactical recommendation is HOLD on existing longs; no fresh buying until price reclaims 10 EMA (289.41) with conviction. A daily close below 265 on elevated volume would signal capitulation risk.
Market Cap
$336.89B
P/E TTM
46.7x
Forward P/E
23.1x
PEG Ratio
1.27
P/B
27.0x
EPS TTM
$5.77
Forward EPS
$11.65
Dividend Yield
0.49%
Beta
1.86
50-Day Avg Price
$311.10
200-Day Avg Price
$265.40
52-Week High
$438.50
52-Week Low
$119.51
FY26 Revenue
$23,232.7M
FY25 Revenue
$18,435.6M
FY24 Revenue
$14,905.4M
FY23 Revenue
$17,428.5M
Revenue YoY Growth FY26
+26.0%
FY26 Gross Margin
50.5%
FY26 Operating Margin
35.3%
FY26 Net Income
$7,265.4M
FY26 Diluted EPS
$5.76
FY25 Diluted EPS
$4.15
FY24 Diluted EPS
$2.90
FY23 Diluted EPS
$3.32
EPS YoY Growth FY26
+38.8%
Cost of Revenue FY26
$11,507M
R&D FY26
$2,376M
SG&A FY26
$1,150M
Effective Tax Rate FY26
12.1%
Cash and Equivalents
$5,579.2M
Receivables
$5,339.7M
Inventory
$4,276.1M
Total Current Assets
$15,610.7M
Total Assets
$23,529.7M
Total Debt
$3,734.6M
Stockholders Equity
$12,470.9M
Tangible Book Value
$10,575.1M
Working Capital
$9,673.5M
Current Ratio
2.63
Net Cash Position
$1.84B
Retained Earnings
$34.95B
Treasury Stock
$31.6B
APIC
$9.24B
Shares Outstanding FY26
1,251M
Operating Cash Flow FY26
$5,857.7M
CapEx FY26
$966.4M
Free Cash Flow FY26
$4,891.3M
FCF Margin FY26
21.1%
FCF TTM
$3,090M
FCF Yield
1.45%
Dividends FY26
$1,270.6M
Buybacks FY26
$3,851.3M
Capital Return FY26
$5.12B
Profit Margin TTM
31.3%
EBITDA TTM
$8,641M
Return on Equity
65.1%
Return on Assets
22.8%
Asset Turnover
~1.0x
Q4 FY26 Revenue
$6,722.2M
Q4 FY26 Gross Profit
$3,478.7M
Q4 FY26 Operating Income
$2,513.5M
Q4 FY26 Net Income
$2,277.3M
Q4 FY26 Diluted EPS
$1.81
Q4 FY26 Revenue QoQ
+15.1%
Q3 FY26 Revenue
$5,841.5M
Q2 FY26 Revenue
$5,344.8M
Q1 FY26 Revenue
$5,324.2M
Q4 FY25 Revenue
$5,171.4M
Days Sales Outstanding
73 days
Receivables YoY Growth
+58%
Strengths
Concerns
LRCX delivered FY26 revenue of $23.2B (+26% YoY) with record gross margins of 50.5% and net income of $7.3B, capitalizing on the AI-driven semiconductor capex upcycle. The company maintains a net cash balance sheet ($1.84B net cash) with exceptional returns (ROE 65.1%) and an aggressive $3.85B annual buyback program. Key risks include a rich 46.7x TTM valuation, a 58% receivables surge outpacing revenue growth, and high cyclicality (Beta 1.86) that warrants disciplined position sizing.
Macro: Fed hiked rates on Sept 16 (Dow fell ~600 points), with Jamie Dimon stating \"It's not clear to me we've slayed inflation.\" Rate-cut pricing has collapsed — 95% probability of zero Fed rate cuts in 2026 (+1.9pp w/w). US recession odds rose +4.0pp to 12% this week. 10-year Treasury just below 5% but rose on the decision. The \"soft-landing-to-no-landing\" regime has shifted decisively hawkish, creating an actively hostile macro overlay for high-multiple tech/semiconductor equipment names.